Famotidine Uses
Famotidine is an H2-receptor antagonist used primarily for treating acid-related gastrointestinal disorders including active duodenal and gastric ulcers, gastroesophageal reflux disease (GERD), erosive esophagitis, and pathological hypersecretory conditions like Zollinger-Ellison syndrome. 1
FDA-Approved Indications
According to the FDA drug label, famotidine is indicated for 1:
In Adults and Pediatric Patients ≥40 kg:
- Active duodenal ulcer (40 mg once daily or 20 mg twice daily for up to 8 weeks)
- Active gastric ulcer (40 mg once daily for up to 8 weeks)
- Symptomatic non-erosive GERD (20 mg twice daily for up to 6 weeks)
- Erosive esophagitis diagnosed by endoscopy (20 mg twice daily or 40 mg twice daily for up to 12 weeks)
In Adults Only:
- Pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias) - starting at 20 mg every 6 hours, up to 160 mg every 6 hours as needed
- Reduction of duodenal ulcer recurrence risk (20 mg once daily for 1 year) 1
Mechanism and Clinical Context
Famotidine works by selectively blocking histamine H2-receptors, reducing gastric acid secretion. It is approximately 20-50 times more potent than cimetidine and 8 times more potent than ranitidine on a weight basis 2.
NSAID-Related Ulcer Prevention
While famotidine has a role in preventing NSAID-induced ulcers, the evidence shows important limitations 3:
- Standard-dose H2-receptor antagonists reduce duodenal ulcers but NOT gastric ulcers in NSAID users
- Double-dose famotidine (e.g., 40 mg twice daily) shows efficacy for both gastric and duodenal NSAID-related ulcers, but primarily in patients with:
- Prior ulcer history
- H. pylori infection
Critical caveat: In H. pylori-negative patients, famotidine showed minimal benefit (23.8% recurrence with placebo vs. 21.4% with famotidine - not statistically significant) 3. This means proton pump inhibitors are generally preferred over H2-receptor antagonists for NSAID gastroprotection in most patients.
Dosing Considerations
Renal impairment requires dose adjustment 1:
- CrCl 30-60 mL/min: reduce to 20 mg once daily or 40 mg every other day
- CrCl <30 mL/min: reduce to 20 mg every other day
Additional Clinical Uses
Beyond FDA-approved indications, famotidine has been studied for:
- Acute urticaria: 20 mg IM showed efficacy comparable to diphenhydramine without sedation 4
- Infant GERD: 0.5-1.0 mg/kg showed some efficacy but may cause agitation and headache 5
Key Clinical Pearls
- Famotidine can be taken with or without food and may be given with antacids 1
- Most duodenal ulcers heal within 4 weeks; consider additional 2-4 weeks if not healed 1
- For NSAID users requiring gastroprotection, PPIs are generally superior to H2-receptor antagonists, especially in H. pylori-negative patients 3
- The combination product DUEXIS® (ibuprofen 800 mg + famotidine 26.6 mg) provides built-in gastroprotection for chronic NSAID users 6